trending Market Intelligence /marketintelligence/en/news-insights/trending/vrhf-hfy6mfg99q4racija2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Daiichi Sankyo completes ¥50B share buyback program

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Daiichi Sankyo completes ¥50B share buyback program

Daiichi Sankyo Co. Ltd. completed a ¥50 billion share buyback program.

The Tokyo-based pharmaceutical company initiated the buyback program Nov. 1, 2017.

The company bought 15,729,200 ordinary shares, or about 4.2% of its issued shares.

As of March 22, US$1 was equivalent to ¥105.72.